First Line Therapy - is Imatinib Still the Best Frontline Treatment? (South Asia)

This debate is a recording of the iCMLf Regional Discussion on CML for South Asia held on 3 June 2026 Regional Experts: Dr Mehreen Ali Khan Armed Forces Bone Marrow Transplant Centre Rawalpindi, Pakistan Professor Hemant Malhotra Sri Ram Cancer and Super-speciality Center Mahatma Gandhi Medical College Hospital Jaipur, India International Experts: Professor Gianantonio Rosti IRCCS/SIRHHC Scientific Institute for Research, Hospitalisation and Health Care Meldola (FC), Italy Professor Susanne Saussele CML Excellence Center Hematology and Oncology University of Mannheim, Mannheim, Germany 00:00 Welcome and Introductions 04:59 Yes! Imatinib Remains the Best Frontline Treatment 22:34 No! There are Better Choices than Imatinib for Frontline Treatment 46:45 Rebuttals, Questions and Comments 01:26:26 Closing Comments